Jill M. Quigley, Director at Terns Pharmaceuticals, Inc. (TERN), sold 23,857 shares at $7.50 ($180K) on 2024-08-02, disclosed to the SEC on 2024-08-05.
Scheduled sale ($180k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.68 | 6,143 | $47K | 26.2% |
| 2 | $7.50 | 8,857 | $66K | 36.9% |
| 3 | $7.50 | 8,857 | $66K | 36.9% |
| Total | $7.55 avg | 23,857 | $180K | 100% |
| Filing → |
| TERN | SELL | 2024-09-11 | $172K | — | Filing → |
| TERN | SELL | 2024-07-17 | $148K | — | Filing → |
| PASG | SELL | 2021-01-22 | $39K | — | Filing → |